Illuminating a blind spot in SARS-CoV-2 immunity.

Luis Graca, Ana Caetano Faria, Ruy M Ribeiro

Abstract readComment

In one paragraph

Article in Nature immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Systemic dysregulation and molecular insights into poor influenza vaccine response in the aging population.Science advances · 2024
Article

4 · The record

Corrections and comments

Comment on
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities.2023

5 · Who and what money

Authors and funding

3 authors.

Luis GracaInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Lisbon Academic Medical Center, Universidade de Lisboa, Lisboa, Portugal. lgraca@medicina.ulisboa.pt.ORCID http://orcid.org/0000-0001-6935-8500

Ana Caetano FariaDepartamento de Bioquímica e Imunologia, Insituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.ORCID http://orcid.org/0000-0002-0604-8510

Ruy M RibeiroTheoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, USA.ORCID http://orcid.org/0000-0002-3988-8241

Funding

The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep DiseasesU54HL143541 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Nathaniel Scott Hafer · 2018 to 2026

$141.0M

NHLBI NIH HHS U54 HL143541

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Antibodies, ViralHumansSARS-CoV-2Antibodies, Viral

Identifiers

PMID37248418

DOI10.1038/s41590-023-01518-w

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.